It was a weird week. Two of the top four rounds were actually large down rounds and a third came with 鈥渞estructuring鈥 and layoff news. Not exactly...
Health, Wellness & Biotech
As we revisit a previously curated list of truly terrible SPAC performers, it鈥檚 clear they鈥檙e closing out the year at a particularly low point.
MasterControl, a decades old Salt Lake City-based company that provides software to manage the development of life science products, reached unicorn...
HistoSonics raised $85 million in funding led by Johnson & Johnson for a futuristic device it says could demolish tumors in patients with liver...
The current state of flux gives us the rare opportunity to build on telehealth successes.
November was another down month in venture, as VCs continue to pull back in a chilly market. Only three firms made a dozen or more deals, making us...
Pharmaceutical giant Amgen is wrapping 2022 with the largest pharmaceutical acquisition of the year (so far).聽
Cuban's company circumvented the pharmacy and insurance companies to directly reach customers. Now, it鈥檚 going to employers.
Telehealth Startups Pivot (Yet Again) As Employer Benefits Get Reevaluated In Layoff-Looming Economy
As tech companies slash their workforces and tighten their 2023 budgets, employers that once embraced shiny new perks to attract and retain talent...
Last week's launch of OpenAI's writing bot showed us that professional writers are just as replaceable as anyone else, and the sector continues to...
November can be slow for funding as Thanksgiving can disrupt the pace of dealmaking. While October saw four funding rounds worth $400M or more, no...


67.1K Followers